Evidence map›Paper›PMID 27252169›Full record

ArticleInnate immunity2016

Distinct TLR-mediated cytokine production and immunoglobulin secretion in human newborn naïve B cells.

Matthew A Pettengill, Simon D van Haren, Ning Li, David J Dowling, Ilana Bergelson, Jop Jans, Gerben Ferwerda, Ofer Levy

Open access · bronzeAbstract read
In one paragraph

Article in Innate immunity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. TLR9-mediated innate immune signaling contributes to acetaminophen-induced injury in the developing lung.American journal of physiology. Lung cellular and molecular physiology · 2026
    Article
  3. Article
  4. Precision adjuvants for pediatric vaccines.Science translational medicine · 2024
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Matthew A PettengillDivision of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA Harvard Medical School, Boston, MA, USA.
Simon D van HarenDivision of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA Harvard Medical School, Boston, MA, USA.
Ning LiDepartment of Immunology and Rheumatology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
David J DowlingDivision of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA Harvard Medical School, Boston, MA, USA.
Ilana BergelsonDivision of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA.
Jop JansDivision of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA Laboratory of Pediatric Infectious Diseases, Department of Pediatrics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Gerben FerwerdaPrecision Vaccines Program, Boston Children's Hospital, Boston, MA, USA Laboratory of Pediatric Infectious Diseases, Department of Pediatrics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Ofer LevyDivision of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA Harvard Medical School, Boston, MA, USA ofer.levy@childrens.harvard.edu.
Boston Children's Hospital · USHarvard University · USShanghai East Hospital · CN

Funding

Dissecting the mechanism of age-specific adjuvant synergy in vitro and in vivoU01AI124284 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI LEVY, OFER · 2016 to 2020
$2.9M
Pediatric Infectious Diseases Research TrainingT32HD055148 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI WESSELS, MICHAEL R · 2008 to 2018
$2.7M
Modeling distinct neonatal purine metabolism to inform vaccine developmentR01AI100135 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI LEVY, OFER · 2012 to 2016
$2.5M
Adenosine Shapes Neonatal Toll-like Receptor FunctionR01AI067353 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI LEVY, OFER · 2006 to 2010
$2.1M
NIAID NIH HHS HHSN272201400052CNIAID NIH HHS R01 AI067353NIAID NIH HHS R01 AI100135NIAID NIH HHS U01 AI124284NICHD NIH HHS T32 HD055148
6 · The paper itself

Abstract

Neonatal innate immunity is distinct from that of adults, which may contribute to increased susceptibility to infection and limit vaccine responses. B cells play critical roles in protection from infection and detect PAMPs via TLRs, that, when co-activated with CD40, can drive B-cell proliferation and Ab production. We characterized the expression of TLRs in circulating B cells from newborns and adults, and evaluated TLR- and CD40-mediated naïve B-cell class-switch recombination (CSR) and cytokine production. Gene expression levels of most TLRs was similar between newborn and adult B cells, except that newborn naïve B cells expressed more TLR9 than adult naïve B cells. Neonatal naïve B cells demonstrated impaired TLR2- and TLR7- but enhanced TLR9-mediated cytokine production. Significantly fewer newborn naïve B cells underwent CSR to produce IgG, an impairment also noted with IL-21 stimulation. Additionally, co-stimulation via CD40 and TLRs induced greater cytokine production in adult B cells. Thus, while newborn naïve B cells demonstrate adult-level expression of TLRs and CD40, the responses to stimulation of these receptors are distinct. Relatively high expression of TLR9 and impaired CD40-mediated Ig secretion contributes to distinct innate and adaptive immunity of human newborns and may inform novel approaches to early-life immunization.

Indexed as

Antibody FormationImmunity, InnateImmunologic MemoryAdultAnimalsB-LymphocytesB-Lymphocyte SubsetsCD40 AntigensCell ProliferationCells, CulturedCytokinesEnzyme-Linked Immunospot AssayHumansImmunoglobulin Class SwitchingInfant, NewbornInterleukin-21CD40 AntigensCytokinesInterleukin-21InterleukinsTLR9 protein, humanToll-Like Receptor 9B lymphocyteclass-switch recombinationcytokineneonatalTLR

Identifiers

PMID27252169
PMCPMC4963298
OpenAlexW2408758561

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.